Biomea Fusion Inc (BMEA)
4.50
-0.03
(-0.66%)
USD |
NASDAQ |
Jun 28, 16:00
4.42
-0.08
(-1.78%)
Pre-Market: 20:00
Biomea Fusion Cash from Investing (Quarterly): -0.035M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -0.035M |
| December 31, 2023 | -0.008M |
| September 30, 2023 | -0.039M |
| June 30, 2023 | -0.417M |
| March 31, 2023 | -1.756M |
| December 31, 2022 | -0.701M |
| September 30, 2022 | 0.225M |
| June 30, 2022 | 7.375M |
| March 31, 2022 | 20.44M |
| Date | Value |
|---|---|
| December 31, 2021 | 4.55M |
| September 30, 2021 | -0.075M |
| June 30, 2021 | 0.68M |
| March 31, 2021 | -38.51M |
| December 31, 2020 | -0.039M |
| September 30, 2020 | -0.012M |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-38.51M
Minimum
Mar 2021
20.44M
Maximum
Mar 2022
-0.4894M
Average
-0.012M
Median
Sep 2020
Cash from Investing (Quarterly) Benchmarks
| Geron Corp | 34.21M |
| Asensus Surgical Inc | 3.00M |
| Geovax Labs Inc | -- |
| Syndax Pharmaceuticals Inc | -99.40M |
| Cartesian Therapeutics Inc | -0.602M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -32.03M |
| Cash from Financing (Quarterly) | 0.116M |
| Free Cash Flow | -105.08M |
| Free Cash Flow Per Share (Quarterly) | -0.8934 |
| Free Cash Flow Yield | -65.47% |